Strata Oncology
Operator of an oncology company intended to accelerate the impact of precision medicine for patients with cancer.
Decision/Risk Analysis
📍 Ann Arbor, MI
Founded 2015
Current Valuation
$590M
as of 2021-Q3
PRIVATE
Operator of an oncology company intended to accelerate the impact of precision medicine for patients with cancer.
Company Profile
Last Round
Series C — $90M (Jul 2021)
Fundraising Status
Series C · $90M · 4y 11mo ago
privateTotal raised $133M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series C | $90M | Jul 2021 | — | $590M |
Health CareBiotechnologyMedical DeviceGeneticsHealth Diagnostics
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2021-Q3. Refreshed quarterly.